AAAAAA
Results: 1-25/131
Authors:
Hemminki, K
Citation: K. Hemminki, Re: Characterization of hereditary nonpolyposis colorectal cancer familiesfrom a population-based series of cases, J NAT CANC, 93(8), 2001, pp. 651-651
Authors:
Plna, K
Hemminki, K
Citation: K. Plna et K. Hemminki, Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families, J NAT CANC, 93(4), 2001, pp. 323-324
Authors:
Wada, T
Louhelainen, J
Hemminki, K
Adolfsson, J
Wijkstrom, H
Norming, U
Borgstrom, E
Hansson, J
Steineck, G
Citation: T. Wada et al., The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction, BJU INT, 87(9), 2001, pp. 876-881
Authors:
Vodicka, P
Soucek, P
Tates, AD
Dusinska, M
Sarmanova, J
Zamecnikova, M
Vodickova, L
Koskinen, M
de Zwart, FA
Natarajan, AT
Hemminki, K
Citation: P. Vodicka et al., Association between genetic polymorphisms and biomarkers in styrene-exposed workers, MUT RES-F M, 482(1-2), 2001, pp. 89-103
Authors:
Hemminki, K
Mutanen, P
Citation: K. Hemminki et P. Mutanen, Genetic epidemiology of multistage carcinogenesis, MUT RES-F M, 473(1), 2001, pp. 11-21
Authors:
Koskinen, M
Vodicka, P
Vodickova, L
Hemminki, K
Citation: M. Koskinen et al., P-32-postlabelling/HPLC analysis of various styrene-induced DNA adducts inmice, BIOMARKERS, 6(3), 2001, pp. 175-189
Authors:
Koskinen, M
Vodicka, P
Hemminki, K
Citation: M. Koskinen et al., Identification of 1-adenine DNA adducts in workers occupationally exposed to styrene, J OCCUP ENV, 43(8), 2001, pp. 694-700
Authors:
Mutanen, P
Hemminki, K
Citation: P. Mutanen et K. Hemminki, Childhood cancer and parental occupation in the Swedish family-cancer database, J OCCUP ENV, 43(11), 2001, pp. 952-958
Authors:
Hemminki, K
Li, XJ
Dong, CH
Citation: K. Hemminki et al., Second primary cancers after sporadic and familial colorectal cancer, CANC EPID B, 10(7), 2001, pp. 793-798
Authors:
Whyatt, RM
Jedrychowski, W
Hemminki, K
Santella, RM
Tsai, WY
Yang, K
Perera, FP
Citation: Rm. Whyatt et al., Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility, CANC EPID B, 10(6), 2001, pp. 581-588
Authors:
Hou, SM
Falt, S
Yang, R
Nyberg, F
Pershagen, G
Hemminki, K
Lambert, B
Citation: Sm. Hou et al., Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNAadduct level and HPRT mutant frequency in lung cancer patients and population controls, CANC EPID B, 10(2), 2001, pp. 133-140
Authors:
Dong, C
Hemminki, K
Citation: C. Dong et K. Hemminki, Risk of multiple primary cancers in nasal cancer patients, EPIDEMIOLOG, 12(3), 2001, pp. 367-369
Authors:
Shugart, YY
Hemminki, K
Vaittinen, P
Kingman, A
Citation: Yy. Shugart et al., Apparent anticipation and heterogeneous transmission patterns in familial Hodgkin's and non-Hodgkin's lymphoma: Report from a study based on Swedish cancer database, LEUK LYMPH, 42(3), 2001, pp. 407-415
Authors:
Louhelainen, J
Wijstrom, H
Hemminki, K
Citation: J. Louhelainen et al., Multiple regions with allelic loss at chromosome 3 in superficial multifocal bladder tumors, INT J ONCOL, 18(1), 2001, pp. 203-210
Authors:
Bykov, VJ
Marcusson, JA
Hemminki, K
Citation: Vj. Bykov et al., Protective effects of tanning on cutaneous DNA damage in situ, DERMATOLOGY, 202(1), 2001, pp. 22-26
Authors:
Hemminki, K
Lonnstedt, I
Vaittinen, P
Citation: K. Hemminki et al., A population-based study of familial cutaneous melanoma, MELANOMA RE, 11(2), 2001, pp. 133-140
Authors:
Li, X
Mutanen, P
Hemminki, K
Citation: X. Li et al., Gender-specific incidence trends in lung cancer by histological type in Sweden, 1958-1996, EUR J CAN P, 10(3), 2001, pp. 227-235
Authors:
Hemminki, K
Li, X
Mutanen, P
Citation: K. Hemminki et al., Familial risks in invasive and in situ cervical cancer by histological type, EUR J CAN P, 10(1), 2001, pp. 83-89
Authors:
Dong, C
Lonnstedt, I
Hemminki, K
Citation: C. Dong et al., Familial testicular cancer and second primary cancers in testicular cancerpatients by histological type, EUR J CANC, 37(15), 2001, pp. 1878-1885
Authors:
Hemminki, K
Jiang, Y
Citation: K. Hemminki et Y. Jiang, Second primary neoplasms after 19281 endocrine gland tumours: aetiologicallinks?, EUR J CANC, 37(15), 2001, pp. 1886-1894
Authors:
Forsti, A
Louhelainen, J
Soderberg, M
Wijkstrom, H
Hemminki, K
Citation: A. Forsti et al., Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer, EUR J CANC, 37(11), 2001, pp. 1372-1380
Authors:
Hemminki, K
Li, XJ
Collins, VP
Citation: K. Hemminki et al., Parental cancer as a risk factor for brain tumors (Sweden), CANC CAUSE, 12(3), 2001, pp. 195-199
Authors:
Ma, X
Yang, K
Lindblad, P
Egevad, L
Hemminki, K
Citation: X. Ma et al., VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium, ONCOGENE, 20(38), 2001, pp. 5393-5400
Authors:
Hemminki, K
Li, XJ
Citation: K. Hemminki et Xj. Li, A population-based study of familial soft tissue tumors, J CLIN EPID, 54(4), 2001, pp. 411-416
Authors:
Zhao, C
Vodicka, P
Sram, RJ
Hemminki, K
Citation: C. Zhao et al., DNA adducts of 1,3-butadiene in humans: Relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points, ENV MOL MUT, 37(3), 2001, pp. 226-230